FR2429591A1 - Procede et composition de traitement du cancer - Google Patents
Procede et composition de traitement du cancerInfo
- Publication number
- FR2429591A1 FR2429591A1 FR7819704A FR7819704A FR2429591A1 FR 2429591 A1 FR2429591 A1 FR 2429591A1 FR 7819704 A FR7819704 A FR 7819704A FR 7819704 A FR7819704 A FR 7819704A FR 2429591 A1 FR2429591 A1 FR 2429591A1
- Authority
- FR
- France
- Prior art keywords
- composition
- particles
- cancer
- treatment method
- cancer treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
- A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782828941 DE2828941A1 (de) | 1978-06-30 | 1978-06-30 | Mittel zur behandlung von krebs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2429591A1 true FR2429591A1 (fr) | 1980-01-25 |
| FR2429591B1 FR2429591B1 (cg-RX-API-DMAC10.html) | 1981-06-26 |
Family
ID=6043278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7819704A Granted FR2429591A1 (fr) | 1978-06-30 | 1978-06-30 | Procede et composition de traitement du cancer |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE2828941A1 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2429591A1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB2024007B (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2508802A1 (fr) * | 1981-07-03 | 1983-01-07 | Thomson Csf | Procede d'hyperthermie medicale utilisant une poudre magnetique par voie sanguine, et dispositif de mise en oeuvre de ce procede |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4323056A (en) * | 1980-05-19 | 1982-04-06 | Corning Glass Works | Radio frequency induced hyperthermia for tumor therapy |
| EP0093757A1 (en) * | 1981-11-12 | 1983-11-16 | Ulf SCHRÖDER | Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof |
| DE3709851A1 (de) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | Nmr-diagnostische fluessigkeitszusammensetzungen |
| DE4419256A1 (de) * | 1994-06-01 | 1995-12-07 | Rau Freiherr Von Nagell Helmut | Verwendung von intravenös applizierbarem Eisen zur Therapie von Tumorerkrankungen und/oder Infektionskrankheiten |
| EP1067971A1 (en) | 1998-04-03 | 2001-01-17 | Du Pont Pharmaceuticals Company | Inorganic material for radioactive drug delivery |
| US11076916B2 (en) | 2015-12-23 | 2021-08-03 | Rhode Island Hospital | Thermal accelerant compositions and methods of use |
| US12702478B2 (en) | 2015-12-23 | 2026-08-11 | Rhode Island Hospital | Devices, methods, and compositions for thermal acceleration and drug delivery |
| CN108430362A (zh) | 2015-12-23 | 2018-08-21 | 罗得岛州医院 | 热促进剂组合物及其使用方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3474777A (en) * | 1966-02-10 | 1969-10-28 | Amp Inc | Method of administering therapeutic agents |
| US3937668A (en) * | 1970-07-15 | 1976-02-10 | Ilse Zolle | Method for incorporating substances into protein microspheres |
| FR2316974A1 (fr) * | 1975-07-11 | 1977-02-04 | Leveen Harry | Procede de traitement de tumeurs par diathermie |
| FR2321305A1 (fr) * | 1975-08-04 | 1977-03-18 | Critical Systems | Procede et appareil pour chauffer les tissus, notamment pour traitement des tumeurs |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3294686A (en) * | 1966-12-27 | Pigment particles coated with organo-alumtnum compounds | ||
| DE1284528B (de) * | 1967-03-08 | 1968-12-05 | Foerster | Einrichtung zur Ausschaltung von biologischem Gewebe durch induktiv erhitzte Koerper mit temperaturstabilisierenden Eigenschaften |
| DE1692771A1 (de) * | 1968-02-24 | 1972-01-05 | Willy Dr Med Seuss | Verfahren zur Zubereitung innerlich oder aeusserlich anwendbarer physiologisch wirksamer Stoffe und danach hergestellte Mittel |
| SE372421B (cg-RX-API-DMAC10.html) * | 1968-04-01 | 1974-12-23 | Minnesota Mining & Mfg | |
| US3720761A (en) * | 1968-10-14 | 1973-03-13 | W Hunter | Injectable radio-pharmaceutical scanning agent and preparation |
| GB1270410A (en) * | 1969-09-25 | 1972-04-12 | Allor Corp | Colloidal composition and method of preparing the same |
| US3743714A (en) * | 1970-12-04 | 1973-07-03 | Cis Radiopharmaceuticals Inc | Novel carrier preparations for injectable radioactive compositions |
| US3927193A (en) * | 1973-05-18 | 1975-12-16 | Hoffmann La Roche | Localization of tumors by radiolabelled antibodies |
| SE431214B (sv) * | 1977-06-02 | 1984-01-23 | Klaus H Mosbach | Sett att framstella magnetiska polymerpartiklar som berare av en foretredesvis biologiskt aktiv substans |
-
1978
- 1978-06-27 GB GB7828040A patent/GB2024007B/en not_active Expired
- 1978-06-30 DE DE19782828941 patent/DE2828941A1/de active Granted
- 1978-06-30 FR FR7819704A patent/FR2429591A1/fr active Granted
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3474777A (en) * | 1966-02-10 | 1969-10-28 | Amp Inc | Method of administering therapeutic agents |
| US3937668A (en) * | 1970-07-15 | 1976-02-10 | Ilse Zolle | Method for incorporating substances into protein microspheres |
| FR2316974A1 (fr) * | 1975-07-11 | 1977-02-04 | Leveen Harry | Procede de traitement de tumeurs par diathermie |
| FR2321305A1 (fr) * | 1975-08-04 | 1977-03-18 | Critical Systems | Procede et appareil pour chauffer les tissus, notamment pour traitement des tumeurs |
Non-Patent Citations (2)
| Title |
|---|
| CA1974 * |
| NV8021/67 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2508802A1 (fr) * | 1981-07-03 | 1983-01-07 | Thomson Csf | Procede d'hyperthermie medicale utilisant une poudre magnetique par voie sanguine, et dispositif de mise en oeuvre de ce procede |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2024007B (en) | 1983-04-27 |
| DE2828941A1 (de) | 1980-01-10 |
| DE2828941C2 (cg-RX-API-DMAC10.html) | 1989-03-16 |
| FR2429591B1 (cg-RX-API-DMAC10.html) | 1981-06-26 |
| GB2024007A (en) | 1980-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lasne et al. | Two-stage malignant transformation of rat fibroblasts in tissue culture | |
| Busch et al. | A nucleolar antigen found in a broad range of human malignant tumor specimens | |
| Bell et al. | A brain extract as a substitute for platelet suspensions in the thromboplastin generation test | |
| FR2393795A1 (fr) | Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique | |
| FI861150L (fi) | Monoklonala antikroppar mot metallkelat. | |
| WO2021207242A3 (en) | Anti-mesothelin antigen-binding molecules and uses thereof | |
| BR112022016715A2 (pt) | Vetores virais que expressam proteínas terapêuticos especificamente em células mieloides e microglia | |
| Orr et al. | Partial characterization of a bone-derived chemotactic factor for tumor cells | |
| CA2144750A1 (en) | Tumor-specific antibodies and antigen | |
| Zupancic | Heterogeneity of uroplakin localization in human normal urothelium, papilloma and papillary carcinoma | |
| Kwon et al. | Optimization of magnetic hyperthermia effect for breast cancer stem cell therapy | |
| DE3686811D1 (de) | Verfahren und zusammensetzung zur behandlung von krebs und nichtmalignen tumoren. | |
| ES467231A1 (es) | Procedimiento y su correspondiente aparato para el trata- miento de metal fundido mediante introduccion de un aditivo de reaccion en el metal fundido. | |
| FR2357514A1 (fr) | Nouvelles substances odorantes a odeur de musc et procede pour leur preparation | |
| Wu et al. | Biosynthesis of Cu2‐xSe Nanocatalyst Within Probiotics for Repolarization of Tumor Associated Macrophages to Boost Mild Photothermal Sensitized Chemodynamic Immunotherapy | |
| FR2335606A1 (fr) | Procede de traitement d'un acier faiblement allie par chauffage et deformation ayant pour but d'ameliorer ses proprietes physiques | |
| IT1264083B1 (it) | Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia. | |
| Karewicz et al. | Surface-modified SPION systems for cancer therapy | |
| GB619886A (en) | Improvements in or relating to the deironing of chromium ores | |
| SU96727A1 (ru) | Способ диффузионного насыщени поверхностных слоев металлических изделий | |
| FR2423223A1 (fr) | Vaccin et dose a injecter pour l'immunotherapie d'une maladie neoplasique | |
| SU116147A1 (ru) | Способ измельчени и электризации частиц синтетического магнетита | |
| Kaszuba-Zwoińska et al. | Cell viability changes in cultured H4 glioma cells upon low frequency pulsed electromagnetic field (7Hz, 30mT) exposure in flow cytometry analysis | |
| ES418052A1 (es) | Procedimiento y aparato para retirar materiales semejantes de un fluido. | |
| Mues et al. | MPI visualization and inductive heating of hybrid implant fibers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse | ||
| ST | Notification of lapse |